REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Glyconex Incorporation (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Glyconex Incorporation Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

GlycoNex Inc. was founded in 2001. It GlycoNex has grown to be the pioneer in Taiwan that combines glycosphingolipid antigen and human monoclonal antibody technologies to develop cancer drugs. Marching into 2012, GlycoNex has possessed advanced and complete technology platform:glycosphingolipid antigen production and identification,monoclonal antibody production, cancer drug screening, stable cell line production for monoclonal antibody, pharmacology/pharmacokinetics assessment.

Headquarters
8F., No.97, Sec. 1, Xintai 5Th Rd, Xizhi Dist
New Taipei City; New Taipei City;

Contact Details: Purchase the Glyconex Incorporation report to view the information.

Website: http://www.glyconex.com.tw

Basic Information
Total Employees:
Purchase the Glyconex Incorporation report to view the information.
Outstanding Shares:
Purchase the Glyconex Incorporation report to view the information.
Financial Auditors:
Purchase the Glyconex Incorporation report to view the information.
Incorporation Date:
February 01, 2001
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
3.97%
Purchase this report to view the information.
2.03%
Purchase this report to view the information.
1.22%
Purchase this report to view the information.
0.37%
Purchase this report to view the information.
0.27%
Subsidiaries
醣聯投資股份有限公司
100%
Company Performance
Financial values in the chart are available after Glyconex Incorporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
480.05%▲
Total operating revenue
833.06%▲
Operating profit (EBIT)
-1.23%▼
EBITDA
-428.06%▼
Net Profit (Loss) for the Period
-124.86%▼
Total assets
-15.05%▼
Total equity
-17.5%▼
Operating Profit Margin (ROS)
6394.62%▲
Net Profit Margin
2077.08%▲
Return on Equity (ROE)
-6.72%▼
Debt to Equity Ratio
-14.87%▼
Quick Ratio
-15.74%▼
Cash Ratio
-6.63%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo